CARBAMAZEPINE

CARBAMAZEPINE was reported 67456 times

CARBAMAZEPINE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 AMYLOID ARTHROPATHY 65 0.9286
1 TOTAL LUNG CAPACITY INCREASED 102 0.3750
2 HUMAN HERPES VIRUS 6 SEROLOGY POSITIVE 80 0.3636
3 SEDATION COMPLICATION 590 0.2310
4 ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC 144 0.2215
5 ANTICONVULSANT DRUG LEVEL INCREASED 340 0.2104
6 CAPILLARITIS 57 0.2065
7 ASTHMA-CHRONIC OBSTRUCTIVE PULMONARY DISEASE OVERLAP SYNDROME 102 0.1950
8 TOTAL LUNG CAPACITY ABNORMAL 57 0.1465
9 SUDDEN UNEXPLAINED DEATH IN EPILEPSY 78 0.1458
10 COMPLEX PARTIAL SEIZURES 160 0.1439
11 CREATININE RENAL CLEARANCE DECREASED 562 0.1403
12 TEMPORAL LOBE EPILEPSY 61 0.1396
13 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 444 0.1367
14 TRIGEMINAL NEURALGIA 535 0.1329
15 LYMPHOCYTE MORPHOLOGY ABNORMAL 73 0.1265
16 LYMPHOCYTE STIMULATION TEST POSITIVE 101 0.1261
17 MULTIPLE DRUG THERAPY 90 0.1194
18 MULTIPLE-DRUG RESISTANCE 365 0.1176
19 ANTICONVULSANT DRUG LEVEL BELOW THERAPEUTIC 84 0.1116
20 PULMONARY VASCULITIS 59 0.1097
21 PARTIAL SEIZURES WITH SECONDARY GENERALISATION 46 0.0983
22 SPIROMETRY ABNORMAL 58 0.0970
23 PSYCHOGENIC SEIZURE 87 0.0930
24 ANTICONVULSANT DRUG LEVEL DECREASED 129 0.0913
25 FOCAL DYSCOGNITIVE SEIZURES 103 0.0904
26 LIP EROSION 65 0.0890
27 PETIT MAL EPILEPSY 433 0.0847
28 MYOCLONIC EPILEPSY 127 0.0837
29 MENINGOMYELOCELE 50 0.0833
30 SIMPLE PARTIAL SEIZURES 65 0.0805
31 CREATININE RENAL CLEARANCE INCREASED 57 0.0762
32 MITE ALLERGY 49 0.0748
33 PARTIAL SEIZURES 391 0.0746
34 AURA 136 0.0728
35 CHANGE IN SEIZURE PRESENTATION 47 0.0726
36 ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE 51 0.0696
37 ELECTROENCEPHALOGRAM ABNORMAL 219 0.0693
38 DYSMORPHISM 162 0.0687
39 ATONIC SEIZURES 58 0.0675
40 EPILEPSY 2038 0.0666
41 MUCOSAL EROSION 60 0.0659
42 STATUS EPILEPTICUS 742 0.0656
43 TONIC CONVULSION 93 0.0656
44 HYPOMANIA 240 0.0652
45 ORAL MUCOSA EROSION 79 0.0642
46 SEIZURE CLUSTER 53 0.0639
47 ASTERIXIS 68 0.0639
48 THERAPEUTIC PRODUCT CROSS-REACTIVITY 57 0.0638
49 SKIN TEST POSITIVE 57 0.0611
50 FOETAL ANTICONVULSANT SYNDROME 72 0.0607
51 INTELLECTUAL DISABILITY 91 0.0599
52 NYSTAGMUS 312 0.0587
53 MYCOTIC ALLERGY 49 0.0573
54 CEREBELLAR SYNDROME 125 0.0570
55 HYPOSPADIAS 118 0.0567
56 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 1445 0.0561
57 GRAND MAL CONVULSION 508 0.0550
58 JAUNDICE CHOLESTATIC 193 0.0546
59 ATAXIA 646 0.0544
60 SYNDACTYLY 45 0.0542
61 BLOOD CALCIUM DECREASED 603 0.0536
62 HUMAN HERPESVIRUS 6 INFECTION 101 0.0534
63 MUCOUS MEMBRANE DISORDER 70 0.0512
64 HYPERAMMONAEMIC ENCEPHALOPATHY 89 0.0511
65 CEREBELLAR ATROPHY 45 0.0511
66 DUST ALLERGY 49 0.0499
67 DEATH NEONATAL 64 0.0460
68 CONVULSION 2493 0.0435
69 ORTHOSTATIC HYPOTENSION 758 0.0435
70 MICROCEPHALY 54 0.0421
71 NEURITIS 65 0.0421
72 PSYCHOMOTOR RETARDATION 118 0.0419
73 STEVENS-JOHNSON SYNDROME 933 0.0419
74 PULMONARY PAIN 122 0.0418
75 CONJUNCTIVITIS ALLERGIC 61 0.0412
76 GENERALISED TONIC-CLONIC SEIZURE 652 0.0394
77 SEDATION 1016 0.0388
78 DERMATITIS EXFOLIATIVE 191 0.0381
79 GAZE PALSY 65 0.0381
80 TOXIC EPIDERMAL NECROLYSIS 571 0.0376
81 SCHIZOPHRENIA 455 0.0374
82 DRUG ERUPTION 663 0.0374
83 HYPERAMMONAEMIA 187 0.0374
84 DRUG WITHDRAWAL CONVULSIONS 66 0.0371
85 PSYCHOMOTOR SKILLS IMPAIRED 92 0.0351
86 DRUG LEVEL DECREASED 348 0.0342
87 DRUG LEVEL INCREASED 544 0.0328
88 SPINA BIFIDA 68 0.0326
89 SEIZURE 3770 0.0326
90 CLEFT PALATE 63 0.0326
91 HYPOREFLEXIA 61 0.0318
92 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 326 0.0317
93 CONVERSION DISORDER 61 0.0314
94 SINUS ARREST 49 0.0312
95 PARAPLEGIA 89 0.0308
96 EXCESSIVE EYE BLINKING 45 0.0304
97 ILLUSION 50 0.0302
98 INHIBITORY DRUG INTERACTION 47 0.0297
99 LYMPHOCYTOSIS 63 0.0292
100 GAMMA-GLUTAMYLTRANSFERASE INCREASED 638 0.0288
101 DEPRESSED LEVEL OF CONSCIOUSNESS 1116 0.0282
102 COORDINATION ABNORMAL 385 0.0276
103 RHINITIS ALLERGIC 122 0.0274
104 STILLBIRTH 130 0.0269
105 HEPATOSPLENOMEGALY 69 0.0269
106 SLOW SPEECH 65 0.0267
107 HYPONATRAEMIA 1492 0.0265
108 RASH MORBILLIFORM 73 0.0263
109 NORMOCHROMIC NORMOCYTIC ANAEMIA 79 0.0263
110 EOSINOPHILIA 456 0.0260
111 COGNITIVE DISORDER 1210 0.0259
112 CEREBRAL ATROPHY 103 0.0258
113 FACIAL PAIN 230 0.0257
114 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 52 0.0255
115 DRUG TOXICITY 347 0.0254
116 ERYTHEMA MULTIFORME 237 0.0254
117 SARCOIDOSIS 120 0.0252
118 DIABETIC NEUROPATHY 124 0.0250
119 WRONG PATIENT RECEIVED PRODUCT 73 0.0249
120 RESPIRATORY SYMPTOM 69 0.0242
121 SELF INJURIOUS BEHAVIOUR 74 0.0242
122 GENERALISED ERYTHEMA 134 0.0235
123 DIPLOPIA 612 0.0235
124 TOXIC SKIN ERUPTION 237 0.0235
125 STRABISMUS 69 0.0235
126 HAEMANGIOMA 54 0.0233
127 CONJUNCTIVAL HYPERAEMIA 83 0.0233
128 RASH MACULO-PAPULAR 518 0.0233
129 MATERNAL DRUGS AFFECTING FOETUS 177 0.0231
130 BRADYPHRENIA 148 0.0226
131 DRUG LEVEL BELOW THERAPEUTIC 125 0.0226
132 STUPOR 72 0.0224
133 SOPOR 296 0.0223
134 DRUG INTERACTION 3531 0.0222
135 PERSECUTORY DELUSION 55 0.0220
136 POTENTIATING DRUG INTERACTION 73 0.0217
137 BEHAVIOUR DISORDER 117 0.0216
138 MYOCLONUS 257 0.0215
139 FORCED EXPIRATORY VOLUME DECREASED 61 0.0215
140 NEUROLEPTIC MALIGNANT SYNDROME 255 0.0215
141 THERAPEUTIC RESPONSE UNEXPECTED WITH DRUG SUBSTITUTION 89 0.0214
142 NASAL POLYPS 104 0.0211
143 AUTISM SPECTRUM DISORDER 116 0.0210
144 ALTERED STATE OF CONSCIOUSNESS 456 0.0210
145 PARADOXICAL DRUG REACTION 76 0.0206
146 AREFLEXIA 55 0.0206
147 CLUMSINESS 56 0.0205
148 CARDIAC MURMUR 177 0.0204
149 DIABETES INSIPIDUS 49 0.0203
150 STARING 49 0.0203
151 PERSONALITY DISORDER 53 0.0202
152 HYPOTONIA 200 0.0200
153 AMMONIA INCREASED 101 0.0198
154 TALIPES 61 0.0196
155 CYTOLYTIC HEPATITIS 65 0.0196
156 HYPOGAMMAGLOBULINAEMIA 128 0.0195
157 NEUROLOGICAL SYMPTOM 111 0.0194
158 BRAIN OPERATION 44 0.0193
159 DRUG EXPOSURE DURING PREGNANCY 654 0.0192
160 BLOOD SODIUM DECREASED 362 0.0192
161 SPEECH DISORDER DEVELOPMENTAL 55 0.0192
162 POSTURE ABNORMAL 62 0.0190
163 DYSARTHRIA 717 0.0190
164 PSYCHOTIC DISORDER 561 0.0190
165 DRUG RESISTANCE 483 0.0188
166 SKIN EROSION 60 0.0186
167 BALANCE DISORDER 1609 0.0186
168 EOSINOPHIL COUNT INCREASED 154 0.0185
169 POLYDIPSIA 73 0.0184
170 COMA SCALE ABNORMAL 53 0.0183
171 EYE MOVEMENT DISORDER 125 0.0182
172 BLOOD CHLORIDE DECREASED 47 0.0182
173 ABORTION INDUCED 170 0.0180
174 MULTIPLE DRUG OVERDOSE INTENTIONAL 58 0.0180
175 AGGRESSION 901 0.0180
176 THERAPEUTIC AGENT TOXICITY 60 0.0180
177 RENAL FUNCTION TEST ABNORMAL 83 0.0179
178 MANIA 293 0.0178
179 COMA 834 0.0175
180 FACIAL BONES FRACTURE 63 0.0175
181 HEART DISEASE CONGENITAL 61 0.0172
182 BIPOLAR DISORDER 187 0.0172
183 MACULE 47 0.0169
184 BRONCHIECTASIS 114 0.0169
185 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 149 0.0168
186 DRUG LEVEL ABOVE THERAPEUTIC 77 0.0168
187 HOMICIDAL IDEATION 68 0.0168
188 PIGMENTATION DISORDER 103 0.0167
189 CATATONIA 87 0.0166
190 PSYCHIATRIC SYMPTOM 122 0.0165
191 TOXICITY TO VARIOUS AGENTS 2772 0.0164
192 COMMUNICATION DISORDER 62 0.0162
193 ATRIOVENTRICULAR BLOCK FIRST DEGREE 70 0.0161
194 ILEUS PARALYTIC 72 0.0161
195 PAPULE 112 0.0159
196 VENTRICULAR SEPTAL DEFECT 90 0.0157
197 PRODUCT SUPPLY ISSUE 112 0.0157
198 BLOOD LACTATE DEHYDROGENASE INCREASED 248 0.0156
199 FACE OEDEMA 263 0.0156
200 SUICIDE ATTEMPT 944 0.0156
201 ABORTION SPONTANEOUS 623 0.0155
202 HYPERTHERMIA 118 0.0154
203 MULTIPLE DRUG OVERDOSE 76 0.0153
204 FEELING OF DESPAIR 70 0.0150
205 OBSESSIVE-COMPULSIVE DISORDER 120 0.0149
206 HYPOTHERMIA 151 0.0149
207 TRISMUS 77 0.0149
208 BLOOD ALKALINE PHOSPHATASE INCREASED 370 0.0149
209 MONOCYTE COUNT INCREASED 54 0.0149
210 PSYCHOMOTOR HYPERACTIVITY 245 0.0147
211 NORMAL NEWBORN 80 0.0147
212 BUNDLE BRANCH BLOCK RIGHT 67 0.0146
213 PNEUMONIA ASPIRATION 362 0.0145
214 DERMATITIS EXFOLIATIVE GENERALISED 50 0.0144
215 AFFECTIVE DISORDER 113 0.0144
216 HEPATOTOXICITY 318 0.0143
217 DEPRESSIVE SYMPTOM 50 0.0142
218 PURPURA 125 0.0141
219 LYMPHADENOPATHY 500 0.0141
220 FOETAL EXPOSURE DURING PREGNANCY 1147 0.0141
221 APLASIA PURE RED CELL 48 0.0139
222 LOGORRHOEA 49 0.0139
223 ABNORMAL BEHAVIOUR 550 0.0139
224 BRUXISM 74 0.0137
225 DIFFICULTY IN WALKING 47 0.0136
226 HEPATIC FUNCTION ABNORMAL 508 0.0136
227 ARTERIOSCLEROSIS CORONARY ARTERY 90 0.0136
228 HYPERPYREXIA 57 0.0134
229 HALLUCINATIONS, MIXED 56 0.0133
230 POISONING 167 0.0133
231 APATHY 190 0.0130
232 GUILLAIN-BARRE SYNDROME 63 0.0130
233 DELUSION 202 0.0130
234 LEUKOCYTOSIS 234 0.0129
235 CHOLELITHIASIS 424 0.0129
236 FEELING DRUNK 96 0.0129
237 HYPERREFLEXIA 45 0.0129
238 HALLUCINATION, AUDITORY 205 0.0129
239 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 66 0.0129
240 SALIVARY HYPERSECRETION 128 0.0128
241 OBSTRUCTIVE AIRWAYS DISORDER 142 0.0128
242 MOTOR DYSFUNCTION 130 0.0127
243 ODYNOPHAGIA 76 0.0127
244 FACE INJURY 48 0.0126
245 ENURESIS 51 0.0126
246 CONGENITAL ANOMALY 97 0.0125
247 INTENTIONAL OVERDOSE 801 0.0125
248 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 97 0.0125
249 HYPERNATRAEMIA 62 0.0124
250 TOXIC ENCEPHALOPATHY 63 0.0124
251 DERMATITIS BULLOUS 90 0.0124
252 OBESITY 196 0.0123
253 RASH GENERALISED 317 0.0122
254 POISONING DELIBERATE 116 0.0122
255 APHASIA 368 0.0122
256 MAJOR DEPRESSION 89 0.0122
257 PREGNANCY WITH IMPLANT CONTRACEPTIVE 57 0.0121
258 LOW BIRTH WEIGHT BABY 96 0.0121
259 SPEECH DISORDER 633 0.0121
260 SOMNOLENCE 2426 0.0120
261 ATRIOVENTRICULAR BLOCK 93 0.0120
262 HEPATOCELLULAR INJURY 170 0.0120
263 SCREAMING 76 0.0119
264 LEFT VENTRICULAR HYPERTROPHY 51 0.0119
265 INTENTIONAL SELF-INJURY 239 0.0118
266 DYSKINESIA 480 0.0118
267 CAESAREAN SECTION 137 0.0118
268 MOBILITY DECREASED 844 0.0117
269 BRAIN OEDEMA 147 0.0116
270 PULMONARY ALVEOLAR HAEMORRHAGE 65 0.0116
271 ATRIAL SEPTAL DEFECT 97 0.0116
272 METABOLIC DISORDER 67 0.0115
273 RASH PUSTULAR 84 0.0115
274 COMPLETED SUICIDE 960 0.0115
275 RESPIRATORY DEPRESSION 141 0.0115
276 INCOHERENT 74 0.0114
277 BRADYKINESIA 67 0.0113
278 ASPARTATE AMINOTRANSFERASE INCREASED 599 0.0113
279 CEREBRAL DISORDER 83 0.0112
280 HYDROCEPHALUS 61 0.0112
281 BLOOD CREATINE PHOSPHOKINASE INCREASED 322 0.0112
282 ALANINE AMINOTRANSFERASE INCREASED 684 0.0111
283 MUSCLE RIGIDITY 133 0.0111
284 PETECHIAE 116 0.0111
285 APLASTIC ANAEMIA 58 0.0111
286 NEURALGIA 270 0.0111
287 AGITATION 815 0.0111
288 MATERNAL EXPOSURE DURING PREGNANCY 979 0.0110
289 VITAMIN D DEFICIENCY 107 0.0110
290 BRAIN INJURY 110 0.0110
291 MOUTH ULCERATION 231 0.0110
292 HEPATITIS CHOLESTATIC 66 0.0109
293 ENCEPHALOPATHY 269 0.0109
294 PRODUCT AVAILABILITY ISSUE 249 0.0109
295 INTESTINAL ISCHAEMIA 60 0.0109
296 MUSCLE SPASTICITY 133 0.0108
297 AFFECT LABILITY 104 0.0108
298 PREMATURE LABOUR 61 0.0108
299 HEPATOMEGALY 106 0.0108
300 FULL BLOOD COUNT ABNORMAL 114 0.0108
301 CENTRAL NERVOUS SYSTEM LESION 148 0.0108
302 THINKING ABNORMAL 200 0.0107
303 GESTATIONAL DIABETES 51 0.0107
304 RESPIRATORY RATE INCREASED 95 0.0107
305 RALES 62 0.0107
306 VISUAL FIELD DEFECT 77 0.0106
307 URINARY INCONTINENCE 315 0.0106
308 DRUG-INDUCED LIVER INJURY 333 0.0106
309 INCONTINENCE 112 0.0106
310 PERSONALITY CHANGE 98 0.0105
311 DECREASED INTEREST 62 0.0105
312 DISSEMINATED INTRAVASCULAR COAGULATION 148 0.0105
313 IMMUNE THROMBOCYTOPENIA 48 0.0105
314 BLOOD BILIRUBIN INCREASED 283 0.0105
315 HEPATITIS ACUTE 68 0.0105
316 DEVELOPMENTAL DELAY 94 0.0104
317 LOSS OF CONSCIOUSNESS 1329 0.0104
318 CHEILITIS 56 0.0103
319 CEREBRAL ISCHAEMIA 53 0.0103
320 SENSORY DISTURBANCE 165 0.0103
321 TIC 56 0.0103
322 ASPIRATION 112 0.0102
323 HEAD INJURY 322 0.0102
324 DRUG ABUSE 846 0.0102
325 AGRANULOCYTOSIS 186 0.0100
326 HEPATITIS 256 0.0100
327 HEMIPARESIS 168 0.0099
328 LYMPHOPENIA 140 0.0099
329 MYDRIASIS 126 0.0098
330 PHARYNGOLARYNGEAL PAIN 52 0.0098
331 SHOCK 225 0.0098
332 RASH VESICULAR 47 0.0097
333 MIOSIS 78 0.0097
334 ANOREXIA 125 0.0097
335 MENTAL IMPAIRMENT 234 0.0096
336 SINUS BRADYCARDIA 93 0.0096
337 DERMATITIS ALLERGIC 121 0.0096
338 C-REACTIVE PROTEIN INCREASED 349 0.0096
339 SKIN LESION 263 0.0096
340 ACUTE HEPATIC FAILURE 131 0.0096
341 VERTIGO 583 0.0096
342 HERPES VIRUS INFECTION 55 0.0095
343 PREGNANCY 191 0.0095
344 POLYURIA 78 0.0095
345 ARTERIOSCLEROSIS 89 0.0094
346 HYPOTHYROIDISM 302 0.0094
347 HYPERTONIA 54 0.0094
348 ORAL DISORDER 69 0.0094
349 ATRIOVENTRICULAR BLOCK COMPLETE 63 0.0094
350 CHOLESTASIS 180 0.0094
351 DISORIENTATION 369 0.0093
352 GRANULOCYTOPENIA 53 0.0093
353 BRADYCARDIA 492 0.0093
354 FALL 3085 0.0093
355 SMALL FOR DATES BABY 46 0.0093
356 ILEUS 115 0.0092
357 LYMPHOCYTE COUNT DECREASED 163 0.0092
358 PROTHROMBIN TIME PROLONGED 55 0.0092
359 PHOTOPHOBIA 172 0.0091
360 MULTI-ORGAN FAILURE 157 0.0091
361 LIVER FUNCTION TEST ABNORMAL 264 0.0091
362 IRRITABILITY 541 0.0090
363 TYPE 1 DIABETES MELLITUS 54 0.0090
364 BLADDER DISORDER 89 0.0090
365 RESTLESSNESS 327 0.0089
366 VASCULITIS 104 0.0089
367 UNRESPONSIVE TO STIMULI 230 0.0089
368 PARANOIA 153 0.0089
369 HYPOALBUMINAEMIA 69 0.0089
370 HEARING IMPAIRED 53 0.0088
371 PARKINSONISM 86 0.0088
372 HYPERPROLACTINAEMIA 57 0.0088
373 HYPOKINESIA 127 0.0087
374 CONFUSIONAL STATE 1413 0.0087
375 THERMAL BURN 62 0.0087
376 MIDDLE INSOMNIA 163 0.0087
377 ACUTE RESPIRATORY DISTRESS SYNDROME 154 0.0087
378 MUSCLE TWITCHING 200 0.0087
379 RHABDOMYOLYSIS 360 0.0086
380 SLUGGISHNESS 88 0.0086
381 PHARYNGITIS 107 0.0086
382 CARDIOMEGALY 106 0.0086
383 BRAIN NEOPLASM 79 0.0086
384 EUPHORIC MOOD 88 0.0086
385 NEUROTOXICITY 150 0.0086
386 HEMIPLEGIA 71 0.0085
387 TRANSAMINASES INCREASED 188 0.0084
388 CONCOMITANT DISEASE AGGRAVATED 52 0.0084
389 GASTROINTESTINAL MOTILITY DISORDER 45 0.0084
390 PHARMACEUTICAL PRODUCT COMPLAINT 217 0.0083
391 BLOOD LACTIC ACID INCREASED 44 0.0083
392 DISTURBANCE IN ATTENTION 449 0.0083
393 MOOD ALTERED 227 0.0083
394 CONJUNCTIVITIS 154 0.0083
395 RESPIRATORY ARREST 227 0.0082
396 DELIRIUM 284 0.0082
397 LEUKOPENIA 409 0.0082
398 HEPATIC ENZYME INCREASED 557 0.0082
399 SINUS TACHYCARDIA 116 0.0082
400 AMNESIA 531 0.0082
401 CIRCULATORY COLLAPSE 139 0.0082
402 BLOOD TRIGLYCERIDES INCREASED 144 0.0081
403 ENCEPHALITIS 56 0.0081
404 BLOOD ALBUMIN DECREASED 64 0.0081
405 MULTIPLE SCLEROSIS RELAPSE 551 0.0080
406 CYANOSIS 126 0.0080
407 DYSTONIA 155 0.0080
408 EXTRAPYRAMIDAL DISORDER 198 0.0080
409 MULTIPLE SCLEROSIS 381 0.0080
410 HAEMATOCRIT DECREASED 158 0.0080
411 DROOLING 55 0.0080
412 PYREXIA 2754 0.0080
413 MENTAL STATUS CHANGES 221 0.0079
414 BLOOD UREA INCREASED 133 0.0079
415 LIVER DISORDER 351 0.0079
416 NEUTROPHIL COUNT INCREASED 81 0.0079
417 OSTEOPENIA 120 0.0079
418 DYSSTASIA 230 0.0079
419 LETHARGY 453 0.0079
420 ELECTROCARDIOGRAM QT PROLONGED 283 0.0079
421 COLITIS ISCHAEMIC 53 0.0078
422 SUDDEN DEATH 83 0.0078
423 DEMENTIA 219 0.0078
424 BODY TEMPERATURE DECREASED 77 0.0078
425 GAIT DISTURBANCE 1495 0.0078
426 PREMATURE BABY 235 0.0078
427 CARDIO-RESPIRATORY ARREST 325 0.0078
428 AKATHISIA 106 0.0078
429 PARALYSIS 111 0.0077
430 UNINTENDED PREGNANCY 81 0.0077
431 ELECTROLYTE IMBALANCE 90 0.0077
432 HEPATIC STEATOSIS 144 0.0077
433 INGUINAL HERNIA 47 0.0077
434 SUICIDAL IDEATION 707 0.0077
435 SENSORY LOSS 62 0.0077
436 TUBULOINTERSTITIAL NEPHRITIS 144 0.0077
437 URINARY RETENTION 256 0.0077
438 EATING DISORDER 163 0.0076
439 HYPOTENSION 1531 0.0076
440 SPINAL OSTEOARTHRITIS 67 0.0076
441 DEPRESSED MOOD 403 0.0076
442 DYSPHAGIA 723 0.0076
443 MEMORY IMPAIRMENT 1043 0.0076
444 OLIGURIA 47 0.0076
445 MENTAL DISORDER 327 0.0075
446 HAEMODIALYSIS 63 0.0075
447 HAEMODYNAMIC INSTABILITY 57 0.0075
448 DYSGRAPHIA 49 0.0074
449 TREMOR 1234 0.0074
450 WHITE BLOOD CELL COUNT INCREASED 285 0.0074
451 SPLENOMEGALY 87 0.0074
452 PEMPHIGOID 56 0.0074
453 BODY TEMPERATURE INCREASED 151 0.0074
454 EYELID OEDEMA 86 0.0074
455 OVERDOSE 1595 0.0074
456 CRYING 267 0.0073
457 FEAR 197 0.0073
458 NAIL DISORDER 64 0.0073
459 RESPIRATION ABNORMAL 50 0.0072
460 HALLUCINATION, VISUAL 152 0.0072
461 ACIDOSIS 55 0.0072
462 LIGAMENT SPRAIN 71 0.0072
463 SLEEP DISORDER 505 0.0071
464 ECCHYMOSIS 49 0.0071
465 DECUBITUS ULCER 58 0.0071
466 RASH ERYTHEMATOUS 340 0.0071
467 WRONG PRODUCT ADMINISTERED 48 0.0071
468 NERVOUS SYSTEM DISORDER 221 0.0071
469 HYPOCALCAEMIA 134 0.0071
470 SYNCOPE 708 0.0071
471 EXPOSURE DURING PREGNANCY 439 0.0071
472 TONGUE DISORDER 51 0.0070
473 ABASIA 174 0.0070
474 VITAMIN D DECREASED 60 0.0070
475 TORSADE DE POINTES 55 0.0070
476 ORAL PAIN 156 0.0070
477 HYPOKALAEMIA 320 0.0069
478 ANGER 234 0.0069
479 PERIPHERAL COLDNESS 95 0.0069
480 BLISTER 385 0.0068
481 JOINT DISLOCATION 72 0.0068
482 DRUG DISPENSING ERROR 104 0.0068
483 FACIAL PARALYSIS 58 0.0068
484 CONDITION AGGRAVATED 2062 0.0068
485 ANAL INCONTINENCE 61 0.0068
486 HEPATIC FAILURE 204 0.0068
487 MEDICATION ERROR 376 0.0068
488 NERVOUSNESS 353 0.0067
489 ACCIDENTAL OVERDOSE 247 0.0067
490 SCAB 77 0.0067
491 MOVEMENT DISORDER 216 0.0067
492 INITIAL INSOMNIA 69 0.0067
493 CARDIAC ARREST 554 0.0067
494 GENERALISED OEDEMA 83 0.0067
495 APNOEA 52 0.0067
496 BLOOD CHOLESTEROL INCREASED 310 0.0066
497 HAND FRACTURE 47 0.0066
498 METABOLIC ACIDOSIS 212 0.0066
499 BLOOD DISORDER 53 0.0066
500 DECREASED ACTIVITY 71 0.0066
501 IMPAIRED DRIVING ABILITY 74 0.0065
502 LIVER INJURY 159 0.0065
503 SEROTONIN SYNDROME 124 0.0064
504 HYPERAESTHESIA 53 0.0064
505 RESPIRATORY FAILURE 470 0.0064
506 SLEEP APNOEA SYNDROME 123 0.0064
507 HYPERCHOLESTEROLAEMIA 62 0.0064
508 CONSTIPATION 1398 0.0064
509 WHEEZING 380 0.0064
510 URINE OUTPUT DECREASED 56 0.0064
511 HYPERGLYCAEMIA 233 0.0064
512 LACERATION 60 0.0064
513 THERAPY PARTIAL RESPONDER 99 0.0063
514 ORAL CANDIDIASIS 83 0.0063
515 EMOTIONAL DISORDER 194 0.0063
516 EAR PAIN 122 0.0063
517 OPTIC NEURITIS 57 0.0063
518 DIABETES MELLITUS 478 0.0063
519 TACHYCARDIA 557 0.0063
520 TYPE 2 DIABETES MELLITUS 211 0.0063
521 PRESCRIBED OVERDOSE 121 0.0062
522 PALLOR 170 0.0062
523 RHINITIS 50 0.0062
524 SCAR 106 0.0062
525 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 321 0.0061
526 CHOKING 120 0.0061
527 HYPOXIA 216 0.0061
528 NODULE 80 0.0061
529 NIGHTMARE 212 0.0061
530 MYOCARDITIS 70 0.0061
531 HYPERSOMNIA 174 0.0061
532 ATRIAL FLUTTER 48 0.0060
533 HALLUCINATION 450 0.0060
534 DEPRESSION 1356 0.0060
535 HYPERLIPIDAEMIA 71 0.0059
536 DIZZINESS 2946 0.0059
537 PULMONARY FIBROSIS 113 0.0059
538 LIP SWELLING 196 0.0059
539 SKIN EXFOLIATION 493 0.0058
540 DYSURIA 215 0.0058
541 RESPIRATORY DISTRESS 161 0.0058
542 TEMPERATURE INTOLERANCE 60 0.0058
543 SPINAL PAIN 68 0.0058
544 PANCREATITIS ACUTE 130 0.0058
545 RED BLOOD CELL COUNT DECREASED 165 0.0058
546 VISION BLURRED 791 0.0058
547 REBOUND EFFECT 65 0.0057
548 TREATMENT NONCOMPLIANCE 311 0.0057
549 FURUNCLE 45 0.0057
550 INTERNATIONAL NORMALISED RATIO INCREASED 161 0.0056
551 ELECTROCARDIOGRAM ABNORMAL 44 0.0056
552 FEEDING DISORDER 113 0.0056
553 LUNG INFILTRATION 49 0.0055
554 MUSCULAR WEAKNESS 627 0.0055
555 POLYNEUROPATHY 66 0.0055
556 PRODUCTIVE COUGH 263 0.0055
557 RASH 2401 0.0055
558 VOMITING 2589 0.0055
559 ROAD TRAFFIC ACCIDENT 229 0.0055
560 THERAPY NON-RESPONDER 246 0.0055
561 PANIC ATTACK 199 0.0055
562 RENAL FAILURE ACUTE 231 0.0054
563 PANCYTOPENIA 304 0.0054
564 FOOT DEFORMITY 60 0.0054
565 PREMATURE DELIVERY 86 0.0054
566 WITHDRAWAL SYNDROME 226 0.0054
567 MALNUTRITION 60 0.0054
568 TOOTHACHE 97 0.0054
569 RASH PAPULAR 120 0.0053
570 PRODUCT SUBSTITUTION ISSUE 307 0.0053
571 GASTRITIS 140 0.0053
572 PYELONEPHRITIS 46 0.0053
573 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 291 0.0053
574 MOOD SWINGS 169 0.0053
575 ATELECTASIS 51 0.0053
576 WRONG DRUG ADMINISTERED 47 0.0053
577 DIZZINESS POSTURAL 51 0.0053
578 LOWER RESPIRATORY TRACT INFECTION 239 0.0052
579 BLOOD POTASSIUM DECREASED 158 0.0052
580 ANKLE FRACTURE 81 0.0052
581 EYE DISORDER 172 0.0052
582 KNEE ARTHROPLASTY 110 0.0052
583 GINGIVAL BLEEDING 71 0.0052
584 BLINDNESS 211 0.0052
585 BEDRIDDEN 68 0.0052
586 NO THERAPEUTIC RESPONSE 63 0.0052
587 ACTIVITIES OF DAILY LIVING IMPAIRED 102 0.0051
588 HYPOAESTHESIA 771 0.0051
589 PRODUCT ADMINISTRATION ERROR 104 0.0051
590 GASTROENTERITIS 75 0.0051
591 WHITE BLOOD CELL COUNT DECREASED 554 0.0051
592 CHROMATURIA 115 0.0051
593 IRON DEFICIENCY ANAEMIA 47 0.0051
594 TOOTH DISORDER 113 0.0051
595 MICTURITION URGENCY 58 0.0051
596 CEREBRAL INFARCTION 124 0.0051
597 THROMBOCYTOPENIA 567 0.0051
598 BREAST PAIN 54 0.0051
599 FOOT FRACTURE 96 0.0051
600 VISUAL ACUITY REDUCED 168 0.0051
601 DIABETIC KETOACIDOSIS 121 0.0050
602 PNEUMONIA BACTERIAL 46 0.0050
603 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 85 0.0050
604 GASTROINTESTINAL PAIN 55 0.0050
605 EMPHYSEMA 50 0.0050
606 ACCIDENT 59 0.0049
607 INTERVERTEBRAL DISC PROTRUSION 108 0.0049
608 OSTEOPOROSIS 203 0.0049
609 THIRST 88 0.0049
610 HAEMOPTYSIS 137 0.0049
611 MUSCLE ATROPHY 62 0.0049
612 WEIGHT INCREASED 1094 0.0049
613 DENTAL CARIES 54 0.0049
614 SKIN LACERATION 53 0.0049
615 INSOMNIA 1291 0.0048
616 HYPOAESTHESIA ORAL 73 0.0048
617 SUBDURAL HAEMATOMA 69 0.0048
618 URINARY TRACT INFECTION 822 0.0048
619 LIMB DISCOMFORT 149 0.0048
620 DIABETES MELLITUS INADEQUATE CONTROL 85 0.0048
621 HEAD DISCOMFORT 85 0.0048
622 OEDEMA PERIPHERAL 585 0.0048
623 HEART RATE DECREASED 168 0.0048
624 ACUTE RESPIRATORY FAILURE 92 0.0048
625 LUNG DISORDER 234 0.0048
626 TARDIVE DYSKINESIA 134 0.0047
627 PANCREATITIS 250 0.0047
628 HYPERTENSION 998 0.0047
629 TACHYPNOEA 64 0.0047
630 PULMONARY CONGESTION 62 0.0047
631 ABSCESS 75 0.0047
632 RASH MACULAR 164 0.0047
633 SKIN REACTION 66 0.0047
634 TINNITUS 215 0.0047
635 DERMATITIS 98 0.0047
636 HAEMATOMA 121 0.0047
637 INFLAMMATION 241 0.0047
638 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 332 0.0047
639 ANXIETY 1328 0.0047
640 KIDNEY INFECTION 91 0.0046
641 SKIN INFECTION 52 0.0046
642 HEPATIC CYTOLYSIS 59 0.0046
643 EAR INFECTION 123 0.0046
644 JAUNDICE 124 0.0046
645 HYPOPHAGIA 117 0.0046
646 MYOCARDIAL ISCHAEMIA 52 0.0046
647 SWELLING FACE 297 0.0046
648 ERYTHEMA 936 0.0045
649 GAIT INABILITY 152 0.0045
650 NECK PAIN 253 0.0045
651 RIB FRACTURE 93 0.0045
652 RED BLOOD CELL SEDIMENTATION RATE INCREASED 50 0.0045
653 ASTHENIA 1699 0.0045
654 JOINT INJURY 96 0.0045
655 PRURITUS GENERALISED 97 0.0045
656 BLOOD PRESSURE DECREASED 298 0.0045
657 LUNG NEOPLASM MALIGNANT 184 0.0045
658 CYSTITIS 142 0.0045
659 PARAESTHESIA 700 0.0044
660 PLATELET COUNT INCREASED 58 0.0044
661 BLOOD CREATININE INCREASED 290 0.0044
662 GASTROOESOPHAGEAL REFLUX DISEASE 357 0.0044
663 EYELID PTOSIS 45 0.0044
664 ISCHAEMIC STROKE 79 0.0044
665 OEDEMA 240 0.0044
666 DRUG PRESCRIBING ERROR 85 0.0044
667 HIATUS HERNIA 57 0.0044
668 FEELING ABNORMAL 1054 0.0044
669 BONE DISORDER 80 0.0044
670 BLOOD POTASSIUM INCREASED 71 0.0044
671 ANGINA PECTORIS 125 0.0044
672 ERECTILE DYSFUNCTION 112 0.0044
673 PHOTOSENSITIVITY REACTION 72 0.0044
674 PULMONARY OEDEMA 195 0.0044
675 SKIN DISCOLOURATION 200 0.0043
676 NEOPLASM 50 0.0043
677 BLOOD PRESSURE FLUCTUATION 104 0.0043
678 HYPOGLYCAEMIA 210 0.0043
679 TREATMENT FAILURE 358 0.0043
680 COAGULOPATHY 72 0.0043
681 ARRHYTHMIA 204 0.0043
682 BLOOD PRESSURE SYSTOLIC INCREASED 84 0.0043
683 PNEUMONIA 1394 0.0043
684 IRRITABLE BOWEL SYNDROME 92 0.0043
685 FRACTURE 81 0.0043
686 MUSCULOSKELETAL CHEST PAIN 66 0.0043
687 BLINDNESS UNILATERAL 60 0.0042
688 POLLAKIURIA 177 0.0042
689 CLOSTRIDIUM DIFFICILE COLITIS 45 0.0042
690 TRANSIENT ISCHAEMIC ATTACK 143 0.0042
691 VENTRICULAR FIBRILLATION 47 0.0042
692 HAEMATEMESIS 107 0.0042
693 VISUAL IMPAIRMENT 523 0.0042
694 CEREBRAL HAEMORRHAGE 151 0.0042
695 CONTUSION 404 0.0042
696 BURNING SENSATION 294 0.0042
697 RETCHING 89 0.0042
698 DISEASE RECURRENCE 198 0.0042
699 THYROID DISORDER 64 0.0041
700 CARPAL TUNNEL SYNDROME 58 0.0041
701 MALAISE 1810 0.0041
702 IMPAIRED WORK ABILITY 88 0.0041
703 GENERAL PHYSICAL HEALTH DETERIORATION 475 0.0041
704 INTENTIONAL PRODUCT MISUSE 358 0.0041
705 POOR QUALITY SLEEP 88 0.0041
706 HYPERHIDROSIS 526 0.0041
707 TOOTH FRACTURE 45 0.0041
708 RASH PRURITIC 221 0.0041
709 DRUG INTOLERANCE 393 0.0041
710 PLATELET COUNT DECREASED 433 0.0041
711 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 195 0.0041
712 HEPATITIS C 49 0.0041
713 GASTRIC ULCER 77 0.0040
714 INTERSTITIAL LUNG DISEASE 196 0.0040
715 HEART RATE INCREASED 401 0.0040
716 STAPHYLOCOCCAL INFECTION 133 0.0040
717 FIBROMYALGIA 98 0.0040
718 RESPIRATORY DISORDER 120 0.0040
719 SWOLLEN TONGUE 125 0.0040
720 AMENORRHOEA 70 0.0040
721 LIMB INJURY 108 0.0040
722 EYE PAIN 224 0.0040
723 ARTHROPATHY 220 0.0040
724 FEELING COLD 110 0.0039
725 GLAUCOMA 76 0.0039
726 MUSCULOSKELETAL STIFFNESS 345 0.0039
727 VENTRICULAR TACHYCARDIA 65 0.0039
728 PULMONARY EMBOLISM 373 0.0039
729 LACTIC ACIDOSIS 127 0.0039
730 UPPER LIMB FRACTURE 78 0.0039
731 BRAIN FOG 61 0.0039
732 BLOOD COUNT ABNORMAL 59 0.0039
733 HYPERSENSITIVITY 720 0.0039
734 BLOOD PRESSURE INCREASED 593 0.0039
735 DRUG INEFFECTIVE 5104 0.0039
736 BRONCHOSPASM 55 0.0039
737 POST PROCEDURAL COMPLICATION 74 0.0038
738 NEUTROPHIL COUNT DECREASED 157 0.0038
739 SEXUAL DYSFUNCTION 45 0.0038
740 PHARYNGEAL OEDEMA 59 0.0038
741 PAIN 2354 0.0038
742 PRODUCT USE IN UNAPPROVED INDICATION 949 0.0038
743 HYPERTHYROIDISM 55 0.0038
744 RESTLESS LEGS SYNDROME 69 0.0038
745 INCREASED APPETITE 72 0.0038
746 HAEMOGLOBIN DECREASED 386 0.0038
747 RENAL DISORDER 175 0.0038
748 RENAL IMPAIRMENT 315 0.0037
749 VIRAL INFECTION 124 0.0037
750 DEEP VEIN THROMBOSIS 242 0.0037
751 HYPERKALAEMIA 130 0.0037
752 MUSCLE TIGHTNESS 60 0.0037
753 UPPER RESPIRATORY TRACT INFECTION 171 0.0037
754 IMMUNODEFICIENCY 55 0.0037
755 RESPIRATORY TRACT INFECTION 96 0.0037
756 BLOOD PRESSURE ABNORMAL 73 0.0037
757 DEAFNESS 96 0.0037
758 PAIN IN JAW 104 0.0037
759 OXYGEN SATURATION DECREASED 206 0.0037
760 WEIGHT DECREASED 1023 0.0037
761 ASTHMA 414 0.0037
762 HEADACHE 2294 0.0037
763 CEREBROVASCULAR ACCIDENT 616 0.0036
764 MIGRAINE 347 0.0036
765 URTICARIA 603 0.0036
766 PRURITUS 1383 0.0036
767 ORAL DISCOMFORT 50 0.0036
768 OROPHARYNGEAL PAIN 333 0.0036
769 HAEMATURIA 123 0.0036
770 ORAL HERPES 70 0.0036
771 COLD SWEAT 63 0.0036
772 PRODUCT PRESCRIBING ERROR 85 0.0036
773 CYST 44 0.0035
774 PRESYNCOPE 86 0.0035
775 PARAESTHESIA ORAL 51 0.0035
776 NEPHROLITHIASIS 162 0.0035
777 NEUTROPENIA 476 0.0035
778 PAIN IN EXTREMITY 1028 0.0035
779 BACTERIAL INFECTION 65 0.0035
780 ANGIOEDEMA 154 0.0035
781 OSTEOMYELITIS 63 0.0035
782 DEHYDRATION 464 0.0035
783 INFLUENZA LIKE ILLNESS 284 0.0034
784 HERPES ZOSTER 198 0.0034
785 NAUSEA 2721 0.0034
786 SWELLING 321 0.0034
787 IMMUNE SYSTEM DISORDER 45 0.0034
788 COUGH 954 0.0034
789 ULCER 54 0.0034
790 DRUG WITHDRAWAL SYNDROME NEONATAL 50 0.0034
791 HYPOACUSIS 145 0.0034
792 STOMATITIS 204 0.0034
793 PLEURAL EFFUSION 204 0.0033
794 LUNG INFECTION 52 0.0033
795 BRONCHITIS 247 0.0033
796 DECREASED APPETITE 775 0.0033
797 CHEST PAIN 618 0.0033
798 CONTRAINDICATED PRODUCT ADMINISTERED 101 0.0033
799 ANAEMIA 636 0.0033
800 ABNORMAL DREAMS 92 0.0033
801 MUSCULOSKELETAL PAIN 174 0.0033
802 CELLULITIS 167 0.0033
803 DIALYSIS 47 0.0033
804 INJURY 232 0.0033
805 ECONOMIC PROBLEM 50 0.0033
806 SEPTIC SHOCK 143 0.0033
807 LOWER LIMB FRACTURE 63 0.0033
808 ANHEDONIA 86 0.0033
809 FATIGUE 2543 0.0033
810 THERAPEUTIC RESPONSE DECREASED 198 0.0033
811 SEPSIS 364 0.0033
812 THROMBOSIS 262 0.0033
813 DRUG EFFECT INCOMPLETE 118 0.0032
814 DRY MOUTH 263 0.0032
815 SYSTEMIC LUPUS ERYTHEMATOSUS 115 0.0032
816 HIP FRACTURE 104 0.0032
817 HUNGER 45 0.0032
818 MELAENA 71 0.0032
819 ABDOMINAL PAIN 750 0.0032
820 DYSPNOEA EXERTIONAL 121 0.0032
821 SKIN DISORDER 107 0.0032
822 OFF LABEL USE 2802 0.0032
823 WRONG TECHNIQUE IN DRUG USAGE PROCESS 116 0.0032
824 ACUTE KIDNEY INJURY 488 0.0032
825 RENAL FAILURE 423 0.0032
826 OSTEOARTHRITIS 135 0.0032
827 CHILLS 373 0.0032
828 DRUG EFFECT DECREASED 171 0.0032
829 MUSCLE SPASMS 582 0.0032
830 PRESCRIBED UNDERDOSE 63 0.0032
831 PERICARDIAL EFFUSION 73 0.0032
832 DRUG WITHDRAWAL SYNDROME 277 0.0032
833 SPINAL FRACTURE 63 0.0031
834 DISABILITY 62 0.0031
835 INFLUENZA 349 0.0031
836 HAEMORRHOIDS 61 0.0031
837 PROTEINURIA 59 0.0031
838 FAECES DISCOLOURED 67 0.0031
839 WOUND 86 0.0031
840 RHINORRHOEA 198 0.0031
841 CATARACT 182 0.0031
842 BONE MARROW FAILURE 62 0.0030
843 ECZEMA 159 0.0030
844 BACK PAIN 695 0.0030
845 ANAPHYLACTIC SHOCK 77 0.0030
846 HEART RATE IRREGULAR 67 0.0030
847 NEUROPATHY PERIPHERAL 282 0.0030
848 MULTIPLE ORGAN DYSFUNCTION SYNDROME 83 0.0029
849 INTENTIONAL DRUG MISUSE 61 0.0029
850 FEMUR FRACTURE 90 0.0029
851 FLUSHING 294 0.0029
852 DYSPHONIA 169 0.0029
853 CYTOMEGALOVIRUS INFECTION 48 0.0029
854 RECTAL HAEMORRHAGE 124 0.0029
855 CARDIAC FAILURE 231 0.0029
856 DRY EYE 142 0.0028
857 DYSPNOEA 1609 0.0028
858 CHRONIC KIDNEY DISEASE 213 0.0028
859 OCULAR HYPERAEMIA 133 0.0028
860 ILL-DEFINED DISORDER 170 0.0028
861 UPPER GASTROINTESTINAL HAEMORRHAGE 47 0.0028
862 HERNIA 54 0.0028
863 NASAL CONGESTION 164 0.0028
864 MUSCULOSKELETAL DISCOMFORT 48 0.0028
865 MUCOSAL INFLAMMATION 73 0.0028
866 ABDOMINAL DISCOMFORT 465 0.0028
867 DRUG ADMINISTRATION ERROR 85 0.0028
868 NASOPHARYNGITIS 510 0.0028
869 SNEEZING 62 0.0028
870 LOCAL SWELLING 48 0.0027
871 GASTROINTESTINAL DISORDER 246 0.0027
872 DYSPEPSIA 270 0.0027
873 ACUTE MYOCARDIAL INFARCTION 80 0.0027
874 DISCOMFORT 165 0.0027
875 METRORRHAGIA 46 0.0027
876 ABDOMINAL PAIN UPPER 555 0.0027
877 PULMONARY HYPERTENSION 56 0.0027
878 INFECTION 389 0.0027
879 NIGHT SWEATS 86 0.0027
880 ANAPHYLACTIC REACTION 147 0.0027
881 FEELING HOT 163 0.0027
882 GASTROENTERITIS VIRAL 47 0.0026
883 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 184 0.0026
884 BLOOD URINE PRESENT 49 0.0026
885 THROAT TIGHTNESS 69 0.0025
886 CHEST DISCOMFORT 261 0.0025
887 ABDOMINAL DISTENSION 266 0.0025
888 EPISTAXIS 190 0.0025
889 MUSCULOSKELETAL DISORDER 48 0.0025
890 CARDIOVASCULAR DISORDER 64 0.0025
891 GALLBLADDER DISORDER 45 0.0025
892 ASCITES 74 0.0025
893 MYALGIA 425 0.0025
894 PALPITATIONS 291 0.0025
895 HAEMATOCHEZIA 137 0.0025
896 PRODUCT USE ISSUE 466 0.0025
897 SINUS DISORDER 49 0.0025
898 ATRIAL FIBRILLATION 240 0.0025
899 HEPATIC CIRRHOSIS 46 0.0024
900 CORONARY ARTERY DISEASE 74 0.0024
901 ARTHRITIS 191 0.0024
902 INTESTINAL OBSTRUCTION 91 0.0024
903 THERAPEUTIC RESPONSE UNEXPECTED 108 0.0024
904 BONE PAIN 141 0.0024
905 CARDIAC DISORDER 223 0.0024
906 PAIN OF SKIN 64 0.0024
907 DIARRHOEA 1526 0.0024
908 CLOSTRIDIUM DIFFICILE INFECTION 51 0.0023
909 DISEASE PROGRESSION 275 0.0023
910 SURGERY 135 0.0023
911 COLITIS 87 0.0023
912 ABDOMINAL PAIN LOWER 58 0.0023
913 LACRIMATION INCREASED 69 0.0023
914 OSTEONECROSIS 75 0.0023
915 SKIN ULCER 59 0.0023
916 LIVER FUNCTION TEST INCREASED 49 0.0023
917 ILLNESS 234 0.0023
918 TOOTH LOSS 47 0.0023
919 UNEVALUABLE EVENT 171 0.0023
920 PERIPHERAL SWELLING 348 0.0023
921 ALOPECIA 442 0.0022
922 DRUG DEPENDENCE 353 0.0022
923 FUNGAL INFECTION 73 0.0022
924 GLOSSODYNIA 49 0.0022
925 EYE SWELLING 81 0.0022
926 PRODUCT DISPENSING ERROR 47 0.0022
927 GASTRIC DISORDER 74 0.0022
928 ARTHRALGIA 889 0.0021
929 VAGINAL HAEMORRHAGE 91 0.0021
930 THERAPY CESSATION 107 0.0021
931 COVID-19 360 0.0020
932 SINUSITIS 210 0.0020
933 DYSGEUSIA 152 0.0020
934 JOINT STIFFNESS 53 0.0020
935 BONE DENSITY DECREASED 63 0.0020
936 ADVERSE DRUG REACTION 180 0.0020
937 THROAT IRRITATION 89 0.0020
938 FLUID RETENTION 100 0.0020
939 INTENTIONAL PRODUCT USE ISSUE 171 0.0020
940 MYOCARDIAL INFARCTION 340 0.0019
941 PNEUMONITIS 53 0.0019
942 THERAPEUTIC PRODUCT EFFECT DECREASED 87 0.0019
943 DIVERTICULITIS 53 0.0019
944 BLOOD GLUCOSE INCREASED 355 0.0019
945 PROCEDURAL PAIN 51 0.0018
946 HAEMORRHAGE 192 0.0018
947 GASTROINTESTINAL HAEMORRHAGE 152 0.0018
948 FLATULENCE 103 0.0018
949 PRODUCT DOSE OMISSION ISSUE 534 0.0018
950 NEOPLASM PROGRESSION 63 0.0018
951 HOT FLUSH 135 0.0018
952 DRUG DOSE OMISSION 295 0.0018
953 IMPAIRED HEALING 58 0.0018
954 INFUSION RELATED REACTION 117 0.0018
955 CARDIAC FAILURE CONGESTIVE 141 0.0018
956 INCORRECT DOSE ADMINISTERED 385 0.0017
957 BLOOD GLUCOSE DECREASED 80 0.0017
958 JOINT SWELLING 201 0.0017
959 RENAL INJURY 48 0.0016
960 INTENTIONAL DOSE OMISSION 46 0.0016
961 EMOTIONAL DISTRESS 195 0.0016
962 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 290 0.0016
963 LABORATORY TEST ABNORMAL 47 0.0016
964 NEOPLASM MALIGNANT 106 0.0016
965 EYE IRRITATION 90 0.0016
966 NEEDLE ISSUE 45 0.0015
967 ACNE 113 0.0015
968 PRODUCT QUALITY ISSUE 201 0.0015
969 ADVERSE EVENT 133 0.0014
970 PRODUCT DOSE OMISSION 92 0.0014
971 PSORIASIS 179 0.0014
972 EXTRA DOSE ADMINISTERED 55 0.0014
973 UNDERDOSE 99 0.0014
974 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 273 0.0013
975 HOSPITALISATION 204 0.0013
976 INCORRECT ROUTE OF DRUG ADMINISTRATION 47 0.0013
977 INJECTION SITE MASS 48 0.0013
978 FEBRILE NEUTROPENIA 86 0.0013
979 SKIN BURNING SENSATION 88 0.0012
980 MALIGNANT NEOPLASM PROGRESSION 122 0.0012
981 INJECTION SITE ERYTHEMA 144 0.0012
982 THERAPY INTERRUPTED 81 0.0011
983 DRY SKIN 146 0.0011
984 DEATH 928 0.0011
985 RHEUMATOID ARTHRITIS 116 0.0010
986 BREAST CANCER 93 0.0010
987 INJECTION SITE BRUISING 77 0.0010
988 NO ADVERSE EVENT 173 0.0010
989 INJECTION SITE PAIN 284 0.0009
990 INJECTION SITE REACTION 63 0.0009
991 INJECTION SITE HAEMORRHAGE 72 0.0009
992 INJECTION SITE PRURITUS 55 0.0008
993 ACCIDENTAL EXPOSURE TO PRODUCT 81 0.0008
994 INJECTION SITE SWELLING 54 0.0007
995 DEVICE MALFUNCTION 48 0.0007